Paper169287
Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
Megyesi K and 3 others. J Clin Endocrinol Metab, 1975. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components. Papers, record 169287. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/169287
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin | Major topic |
| Peptides | Major topic |
| Acromegaly | |
| Anorexia Nervosa | |
| Blood Glucose | |
| Female | |
| Fibrosarcoma | |
| Growth Hormone | |
| Humans | |
| Hypoglycemia | |
| Hypopituitarism | |
| Pregnancy | |
| Protein Binding | |
| Receptors, Cell Surface |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6990627 | Paraneoplastic syndromes. | West J Med | 1980 | https://conductscience.org/library/papers/6990627 | PubMed |
| 6357116 | Peripheral tissue metabolism in cancer-bearing man. | Ann Surg | 1983 | https://conductscience.org/library/papers/6357116 | PubMed |
| 2771956 | Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2771956 | PubMed |
| 2159026 | Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2159026 | PubMed |
| 1254732 | Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation. | J Clin Invest | 1976 | https://conductscience.org/library/papers/1254732 | PubMed |
| 976640 | The excretion of insulin in urine. | Diabetologia | 1976 | https://conductscience.org/library/papers/976640 | PubMed |
| 640301 | NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. | Diabetologia | 1978 | https://conductscience.org/library/papers/640301 | PubMed |
| 447829 | Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. | J Clin Invest | 1979 | https://conductscience.org/library/papers/447829 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/169287
GET https://conductscience.org/api/papers/v1/169287/authors